Synthesis of antibiotics

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

Organisationseinheiten

Externe Organisationen

  • Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)419-445
Seitenumfang27
FachzeitschriftCurrent Topics in Microbiology and Immunology
Jahrgang398
PublikationsstatusVeröffentlicht - 5 Okt. 2016

Abstract

The synthesis of b-lactams, tetracyclines, and erythromycins as three of the major families of antibiotics will be described herein. We will describe why these antibiotics were the ultimate synthetic targets in the past and how modern synthetic organic chemistry has evolved to address these challenges with new, improved strategies and methods. An additional aspect we would like to highlight here is the fact that these first syntheses had to be particularly creative as most of the modern synthetic methods were not available at that time, or were developed in the course of these syntheses.

ASJC Scopus Sachgebiete

Zitieren

Synthesis of antibiotics. / Kalesse, Markus; Böhm, Andreas; Kipper, Andi et al.
in: Current Topics in Microbiology and Immunology, Jahrgang 398, 05.10.2016, S. 419-445.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Kalesse M, Böhm A, Kipper A, Wandelt V. Synthesis of antibiotics. Current Topics in Microbiology and Immunology. 2016 Okt 5;398:419-445. doi: 10.1007/82_2016_502
Kalesse, Markus ; Böhm, Andreas ; Kipper, Andi et al. / Synthesis of antibiotics. in: Current Topics in Microbiology and Immunology. 2016 ; Jahrgang 398. S. 419-445.
Download
@article{26a6e69ed25d45ee9180c82c0afbe621,
title = "Synthesis of antibiotics",
abstract = "The synthesis of b-lactams, tetracyclines, and erythromycins as three of the major families of antibiotics will be described herein. We will describe why these antibiotics were the ultimate synthetic targets in the past and how modern synthetic organic chemistry has evolved to address these challenges with new, improved strategies and methods. An additional aspect we would like to highlight here is the fact that these first syntheses had to be particularly creative as most of the modern synthetic methods were not available at that time, or were developed in the course of these syntheses.",
author = "Markus Kalesse and Andreas B{\"o}hm and Andi Kipper and Vanessa Wandelt",
year = "2016",
month = oct,
day = "5",
doi = "10.1007/82_2016_502",
language = "English",
volume = "398",
pages = "419--445",
journal = "Current Topics in Microbiology and Immunology",
issn = "0070-217X",
publisher = "Springer Verlag",

}

Download

TY - JOUR

T1 - Synthesis of antibiotics

AU - Kalesse, Markus

AU - Böhm, Andreas

AU - Kipper, Andi

AU - Wandelt, Vanessa

PY - 2016/10/5

Y1 - 2016/10/5

N2 - The synthesis of b-lactams, tetracyclines, and erythromycins as three of the major families of antibiotics will be described herein. We will describe why these antibiotics were the ultimate synthetic targets in the past and how modern synthetic organic chemistry has evolved to address these challenges with new, improved strategies and methods. An additional aspect we would like to highlight here is the fact that these first syntheses had to be particularly creative as most of the modern synthetic methods were not available at that time, or were developed in the course of these syntheses.

AB - The synthesis of b-lactams, tetracyclines, and erythromycins as three of the major families of antibiotics will be described herein. We will describe why these antibiotics were the ultimate synthetic targets in the past and how modern synthetic organic chemistry has evolved to address these challenges with new, improved strategies and methods. An additional aspect we would like to highlight here is the fact that these first syntheses had to be particularly creative as most of the modern synthetic methods were not available at that time, or were developed in the course of these syntheses.

UR - http://www.scopus.com/inward/record.url?scp=85007321220&partnerID=8YFLogxK

U2 - 10.1007/82_2016_502

DO - 10.1007/82_2016_502

M3 - Article

C2 - 27704271

AN - SCOPUS:85007321220

VL - 398

SP - 419

EP - 445

JO - Current Topics in Microbiology and Immunology

JF - Current Topics in Microbiology and Immunology

SN - 0070-217X

ER -

Von denselben Autoren